Kim, Jeong Ho, et al. “Clinical Outcomes of the Sequential Use of Pazopanib Followed by Everolimus for the Treatment of Metastatic Renal Cell Carcinoma: A Multicentre Study in Korea”. Canadian Urological Association Journal, vol. 12, no. 1, Nov. 2017, pp. E15-20, doi:10.5489/cuaj.4644.